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Abstract
Purpose of Review Spasticity is a part of the upper motor
neuron syndrome and can result in reduced function.
Reduction of the complications may be facilitated by early
intervention, making identification of stroke patients at
high risk for developing spasticity essential.
Recent Finding Different predictors of poststroke spastic-
ity (PSS) have been suggested in different studies,
including development of increased muscle tone, greater
severity of paresis, sensory impairment, and low Barthel
Index score. The results also indicate that early identifi-
cation of factors predictive of PSS is beneficial.
Summary In this review article, the results of five studies
are discussed and they all support the notion that early
identification of factors predictive of PSS is beneficial and
could help to identify individuals who would benefit most
from intervention and thereby provide better outcome.
Keywords Poststroke spasticity  Stroke rehabilitation 
PSS  Risk factors  Outcome  Review
Introduction
Spasticity is a part of the uppermotor neuron syndrome and can
result in reduced function. The impact of spasticity on post-
stroke recovery may not be obvious at first, and hence not
addressed in the early phase. Spasticity in the upper limb
spasticity has been found to be associated with reduced arm
function and lower levels of independence, and with an
astounding four-fold increase indirect care costs during thefirst-
year poststroke [1, 2]. It seems as if spasticity in patients with
stroke ismore common in the upper extremity than in the lower
limbs [3•], The frequency of spasticity in the upper limb varies
from7 % to38 %[2, 4–6] in thefirst 12 months, andwas found
to be 46 % in patients with initial impaired arm function [7].
Early recognition of spasticity, and identification of
predictors to assist rehabilitation professionals recognize
which stroke patients are at risk for spasticity to develop, is
suggested to yield earlier treatment of poststroke spasticity
(PSS) and possibly better outcomes [8]. It would be helpful
to know which factors can identify patients are at high risk
of developing severe (PSS) especially during the initial
admission poststroke. Increased knowledge regarding the
pathophysiology, evolution of the condition, epidemiology,
and therapeutic intervention for PSS, along with identify-
ing PSS risk factors, is a road for better care [9].
The aim of this review is to present predictors that will
help to identify which patients are at risk for the devel-
opment of PSS.
Materials and Methods
A search was performed using the following terms: natural
history OR clinical course OR prevalence AND stroke
AND spasticity, with the limitation to publications written
in English. The results were further limited to studies
focusing on the prediction of spasticity (up to 12 months
poststroke).
Various studies have assessed spasticity at various time
points poststroke, (Table 1). Although a time lag may exist
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between stroke onset and the onset of PSS, this has only been
addressed in a few studies. In a classic study from Som-
merfeld et al. [10], at baseline (mean: 5.4 days), 21 % of
patients with first-ever stroke were deemed to have spasticity
according to the Modified Ashworth Scale (MAS score[0),
while 19 % demonstrated spasticity at 3 months poststroke.
Patients with disabling spasticity score significantly worse
than those with mild spasticity on the modified Rankin Scale
(mRS P = 0.009) and the Barthel Index (BI P = 0.005),
suggest that treatment needs are not the same for all patients
with spasticity, and those with disabling spasticity must be
distinguished from those with less serious deficits [2].
Predictors of Spasticity Development
Not much has been published regarding the onset and
course of spasticity during the first-year poststroke.
Although the prediction of late-developing PSS is likely
improved using measures of early PSS, the time point at
which these measures should be taken is unclear. Different
studies have shown some similar and some varied results.
Lundstrom et al. [3] included 49 subjects with any
paresis after first-ever stroke and examined them at base-
line (day 2–10 after stroke) and at 2 follow-up time points,
at 1 and 6 months. At all time occasions, muscle tone
(assessed by MAS), global disability (assessed by the
mRS), stroke severity, paresis severity, and sensory dis-
turbance (all assessed by the National Institutes of Health
Stroke Scale [NIHSS]) were recorded to determine the
occurrence of and risk factors for PSS. At baseline, 4 % (2
of 49) of patients had PSS (MAS score C1). Early PSS
development was further observed in 27 % (13 of 48) of
patients at 1 month and 23 % (11 of 47) at 6 months.
Spasticity in the upper limb was observed more often than
in the lower limb: at 1 month, 25 % of patients had PSS in
the upper limb versus 13 % in the lower limb, and at
6 months the rates were 22 and 13 %, respectively. Dis-
abling spasticity was observed in 13 % (6 of 47) of patients
at the 6-month follow-up [3]. Multiple logistic regression
analysis found severe paresis of the arm ([2 points on item
5 of the NIHSS) at baseline to be associated with a higher
risk for spasticity (P\ 0.001) as early as 1 month after
stroke (Table 2). Smoking and younger age was also
associated with increased risk. The six patients displaying
disabling spasticity throughout the follow-up period had
initial severe arm paresis as well (P\ 0.002).
A larger study [5•] of 301 subjects with first-ever stroke
and limb paresis were included and examined in the acute
phase after stroke (within 5 days) and again 6 months later.
At both time points, the degree and pattern of paresis and
muscle tone (assessed via the British Medical Research
Council scale and MAS) as well as Barthel Index were
evaluated [5•]. Of the 211 subjects reassessed at 6 months,
Table 1 Poststroke spasticity in patients admitted to a stroke unit
Study N Time after
stroke
Evaluation method Predictors of spasticity Prevalence of spasticity
Opheim A et al. (2014) 117 Up to
12 months
MAS Reduced sensorimotor function Spasticity at 3 and 10 days and
4 weeks, 24, 43, and 46 % of.
At 12 months, 46 %
Reduced sensation






Moderate increase in muscle tone
at baseline and/or first follow-up
(MAS = 2), low Barthel Index
at baseline, hemispasticity,
involvement of more than two
joints at first follow-up, and
paresis at any assessment point
Spasticity:
At 2 weeks: 24.5 %
At 6 weeks: 26.7 %
At 4 months: 21.7 %
Severe spasticity: 9.6 %
(MAS C 3)






More severe paresis in the
proximal and distal limb
muscles had a higher risk for
developing spasticity
42.6 % had developed spasticity at
6 months. A more severe degree
of spasticity (Modified
Ashworth Scale[ or = 3) was
observed in 15.6 % of all
patients
Table 2 Risk factors significantly predictive of permanent poststroke
spasticity [6•]
Risk factor P value
Any paresis in affected limb \0.001
MAS C2 in C1 joint within median 6 weeks poststroke 0.01
[2 joints affected by increased muscle tone 0.002
Hemispasticity within median 6 weeks poststroke 0.01
Lower Barthel Index score at baseline 0.002
More severe paresis at median 16 weeks poststroke 0.02
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42.6 % (n = 90) had developed PSS (MAS score C1). A
more severe degree of spasticity (MAS score C3) was
observed in 15.6 % (n = 33) of these subjects. Logistic
regression analysis confirmed that subjects with a more
severe degree of paresis (BMRC grades 1 and 0) in the
proximal and distal muscles of the upper and lower limbs
during the acute stage had a higher risk of developing PSS
(P B 0.001). Furthermore, the development of PSS in the
upper and lower limbs was more frequent in subjects with
initial hemihypesthesia than in subjects without sensory
deficits (OR = 2.27; P = 0.011). However, the sensory
examination included only sensitivity to light touch. The
conclusion was that predictors for the development of PSS
included a severe degree of paresis and hemihypesthesia at
stroke onset. Lower BI at 6 months, were more common in
subjects with PSS (P\ 0.001) compared to the group
without PSS at 6 months [5•].8
Wissel and coworkers [6•] presented a study of 94 subjects
without preexisting spasticity who were examined at 6 days
poststroke (baseline; range 1–14 days), 6 weeks (range
4–12 weeks), and 16 weeks (range 12–24 weeks). At all
time points, muscle tone (MAS), pain, paresis, and BI score
were recorded to identify risk factors for the development of
PSS. Similar to other studies, early development of PSS was
observed, with 24.5 % (23 of 94) of subjects with stroke
developing an increase in muscle tone (MAS score[0)
within 2 weeks after stroke [6•]. Spasticity was observed in
26.7 % (23 of 86) of patients by the first follow-up at 6 weeks
after stroke and in 21.7 % (18 of 83) by 16 weeks after
stroke. Among all subjects who developed PSS at any time
during the course of the study, 98 % exhibited PSS by the
first follow-up (median of 6 weeks). Subjects with PSS had
significantly higher incidences of pain (P\ 0.001) and
nursing home placement (P\ 0.05) and lower BI
(P = 0.035) scores than subjects with normal muscle tone
[6•]. Predictors of the development of permanent spasticity
are shown in Table 2. Severe spasticity (MAS score C3)was
predicted by lower BI scores (median score 63.3, compared
to 80.6 in patients without spasticity) at baseline and mod-
erate muscle tone (MAS score = 2) at baseline to 6 weeks
poststroke. Presence of hemiparesis correlated with PSS at
first (P = 0.02) and second (P = 0.005) follow-up.
Hemispasticity and increased muscle tone (MAS score C1)
in more than two joints at 6 weeks, and more severe degrees
of paresis at 16 weeks, were risk factors for permanent
spasticity. Severity of paresis at the second follow-up
(12–24 weeks after stroke) significantly correlated with
degree of spasticity (P = 0.02). Lower BI at baseline pre-
dicted development of more severe spasticity at final follow-
up (P = 0.002). None of the baseline characteristics, such as
age, sex, location or type of stroke, or smoking, was signif-
icantly associated with the development of PSS in this
sample [6•].
Another study [11] investigated patients admitted to a
rehabilitation unit after a first-ever ischemic stroke.
(N = 163) Again, MAS was used for assessing upper limb
spasticity. The upper limb function was assessed and for
ADL, the Barthes Index was used. Upper limb spasticity was
defined as MAS of 1 or greater. In this sample [11], upper
limb spasticity occurred in 1/3 of the patients (54 patients) at
3 months after stroke. Development of spasticity at later
stages of the stroke was infrequent, occurring in only 28
patients (17 %). However, in almost half of those with
moderate spasticity (MAS 2) at 3 months, the spasticity
progressed to severe (MAS 3). As predictors, poor upper
limb functionwas themost important factor for ‘‘moderate to
severe spasticity’’ (MAS C2) (P\ .001) [11],
A recent study [12•] which included 117 patients who
had experienced a stroke for the first time and had a doc-
umented upper extremity paresis day 3 poststroke were
consecutively included from a comprehensive stroke unit.
Evaluations were made at admission and at 3 and 10 days,
4 weeks and 12 months poststroke. Upper limb spasticity
in elbow flexion/extension and wrist flexion/extension was
assessed (at all time points except admission) with modi-
fied Ashworth scale (MAS). ‘‘Any spasticity’’ was regarded
as MAS C1, and ‘‘severe spasticity’’ was regarded as
MAS C2 in any of the muscles. Fugl-Meyer assessment
scale was used to assess sensorimotor function, sensation,
pain and joint range of motion in the upper limb. The
results from this scale together with demographic and
diagnostic information were included in both univariate
and multivariate logistic regression analysis models. Due to
the long follow-up there were dropouts and in the logistic
regression analysis, data from 76 patients were included
[12•]. The results indicated that sensorimotor function was
the most important predictor both for ‘‘any’’ and ‘‘severe
spasticity’’ 12 months poststroke. In addition, spasticity
4 weeks poststroke was a significant predictor for ‘‘severe
spasticity.’’ The best prediction model for ‘‘any spasticity’’
was observed 10 days poststroke (85 % sensitivity, 90 %
specificity). The best prediction model for ‘‘severe spas-
ticity’’ was observed 4 weeks poststroke (91 % sensitivity,
92 % specificity) [12•].
Conclusion
Despite evidence supporting the possibility that these
additional predictive factors may be of clinical impor-
tance—particularly motor impairment, neurologic and
sensory deficit, associated diseases, and surrogate markers
from magnetic resonance imaging such as lesion volume
and location—further investigation is warranted in order to
validate their correlation with PSS development.
184 Curr Phys Med Rehabil Rep (2016) 4:182–185
123
Further research to determine the clinical utility of
models to predict the onset of PSS and other common
poststroke complications is also warranted. Additionally,
research to determine the specificity of how upper and
lower limb spasticity contributes to the outcome and
quality of life would be welcome to this field. These
findings point out that individualized assessment of dif-
ferent locations and degrees of spasticity and paresis need
to be carefully documented before starting any treatment.
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